Increasing diversity in clinical trials and all research is vital in understanding how health interventions can affect patients differently. Altura CEO Pete Fronte, MBA chaired a forum on this topic at the DIA 2024 Global Annual Meeting in June. Dr. Karen Correa, PhD,BCMAS, Takeda; Dr. Jim Schultz, Neighborhood Healthcare; and clinical trial patient Mario DuCre discussed how community health centers (CHCs) and life science companies can play a key role in boosting clinical study involvement among underrepresented populations. View the presentation: #diversity #healthequity #clinicalresearch #chcs #lifesciences
Altura ’s Post
More Relevant Posts
-
🌍🌱 World Population Day: Driving Clinical Trials for a Healthier Future. Croissance Clinical Research (CCR) celebrate the vital role of clinical trials in advancing global health. With our growing population, the demand for innovative treatments and medical breakthroughs has never been greater. Our commitment to robust and inclusive clinical trials ensures that new therapies are safe, effective, and accessible to all. By fostering international collaboration, we aim to improve health outcomes worldwide, tackling the unique challenges that come with diverse populations. Together, let's strive for a healthier, more equitable future. 🌐🧬 #ClinicalTrials #GlobalHealth #Innovation #Healthcare #PopulationGrowth Satish Marukurthi Jacob Odika Apollo
To view or add a comment, sign in
-
Award Winning Health Equity Specialist | Amplifying Diverse Voices for Accessible, Equitable, and Impactful Outcomes | AuDHD and Chronic Illness Advocate
My latest post in the A-Z of health research equity series is now available to read! In this one I'm talking about the importance of sharing research results with the participants that invested their time and experiences. Without participants, we would not have research, the least we can do is thank them and let them know what they have contributed to. Read the full post here: https://lnkd.in/eGVEyZ_n #PatientsFirst #PatientEngagement #HealthResearchEquity #TheCOUCHWay
If you had participated in a clinical trial, would you want to know the results when the study ended? We certainly would. It seems like an obvious thing to do, but despite contributing their time, effort, and bodies to research, many participants never receive feedback on study results. And for the few participants who do, they often don’t get a say in how they receive the feedback. Learn more about patient feedback by reading Dr Heidi Green's latest A–Z of Health Research Equity blog series instalment. Find out more here: https://lnkd.in/gaM3uKXx #PatientFeedback #PatientEngagement #TrialResults #HealthResearchEquity #TheCOUCHWay
The A-Z of Health Research Equity: F is for Feedback
To view or add a comment, sign in
-
Founder & President of CliniLink Health & MindLeaf Technologies | Patient Engagement and Compliance Expert | Determined to Change the Future of Clinical Trial Participation | Weekend Photographer
Diversity in clinical trials is not just important—it's essential. Ensuring that research includes a wide range of participants leads to more reliable and comprehensive findings that can benefit everyone. When trials lack diverse participants, essential differences between groups can be missed. It can lead to incomplete data and treatments that may only work well for some, affecting overall health outcomes. We help you design inclusive clinical trials that accurately represent all populations. Our tailored approach ensures that your research is accurate and equitable, driving better health outcomes for everyone. Explore the strategic solutions we offer to enhance the inclusivity and effectiveness of your clinical trials. Visit https://lnkd.in/eSG9eYRa to learn more. #clinilinkhealth #CliniLink #DiversityInResearch #ClinicalTrials #PatientDiversity #ethicalresearch
To view or add a comment, sign in
-
Diversity in clinical trials is not just important—it's essential. Ensuring that research includes a wide range of participants leads to more reliable and comprehensive findings that can benefit everyone. When trials lack diverse participants, essential differences between groups can be missed. It can lead to incomplete data and treatments that may only work well for some, affecting overall health outcomes. We help you design inclusive clinical trials that accurately represent all populations. Our tailored approach ensures that your research is accurate and equitable, driving better health outcomes for everyone. Explore the strategic solutions we offer to enhance the inclusivity and effectiveness of your clinical trials. Visit https://lnkd.in/eyxKjPbg to learn more. #clinilinkhealth #CliniLink #DiversityInResearch #ClinicalTrials #PatientDiversity #ethicalresearch
To view or add a comment, sign in
-
Partnering with global HR, CSR, nonprofit, and higher ed leaders in healthcare to develop and institutionalize sustainable people, culture, talent, and social impact strategies.
Clinical research should reflect the diversity of the population it serves. Today, let's highlight the importance of diverse participation in trials and the impact it has on advancing healthcare for all communities. #DiversityInClinicalTrials #ResearchInclusion
To view or add a comment, sign in
-
🗝️ Better access to #clinicaltrials means a stronger health research system. The Approaches for Accessible Clinical Trials symposium recently hosted by Clinical Trials BC sparked great conversation around removing barriers to participation in clinical trials. ⏩ Hear from researchers, clinicians and people with lived experience as they explore novel pathways, technologies and approaches to make the clinical trials experience culturally safe, trauma-informed, inclusive, accessible, and available to all British Columbians. https://bit.ly/4bAbJhG #CTBC2023 #healthresearch
To view or add a comment, sign in
-
Faculty Spotlight on Mayu Sekiguchi Runge, MD Dr. Runge recently published “Advancing Primary Care Access: Exploring the Impact of the Virtual Waiting Room on the Quadruple Aim,” in the Journal of General Internal Medicine. The study examines the effects of a virtual waiting room (VWR) program on improving patient access and increasing primary care provider (PCP) utilization in community health centers. Read more: bit.ly/46LH13m
To view or add a comment, sign in
-
Diversity in clinical trials is more than a checkbox. It's about better science and equitable healthcare. In Latin America, we're making strides: • Engaging community leaders • Offering flexible study visits • Providing transportation support In a recent cardiovascular study, these simple changes increased Latino participation by 30%. Remember: Every participant brings unique value to research. How are you enhancing diversity in your trials? #ClinicalTrialDiversity #HealthcareInnovation #LatinAmerica
To view or add a comment, sign in
-
Diversity in clinical trials is crucial for developing treatments that are safe and effective for everyone. By including underrepresented populations, we ensure that medical research reflects the real world and addresses health disparities. This not only improves access to new therapies for those who need them most but also builds trust and inclusion in healthcare. #DiversityInClinicalTrials #RaceEthnicity #HealthEquity #ClinicalTrials #ScientificRigor
To view or add a comment, sign in
-
The FY 25 Labor-HHS appropriations bill which contains funding and policy provisions related to the National Institutes of Health (NIH) that undermine biomedical research and are inconsistent with current efforts to prioritize women’s health research. Your voice can make a significant impact. We urge you to contact your representative and express your concerns about these proposed changes to ensure that women’s health research continues to receive the attention and funding it deserves. Learn how: https://lnkd.in/em925-jE
To view or add a comment, sign in
626 followers